MAMMÔ 2026 Day 1 Highlights: From Early Detection and Precision Diagnostics to Treatment De-escalation and Global Breast Cancer Care
FDA Approved Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer
Who Shaped Oncology in the First Half of 2026: Breaking Down Approvals by Indications
Armenia Grants World's First Marketing Authorizations for BOT+BAL in MSS mCRC
Bogda Koczwara Named Candidate for UICC Board of Directors 2026–2028
The Cancer Elimination Collaboration Welcomed Ophira Ginsburg and Dorothy Keefe to the University of Sydney
Emanuela Palmerini: Connecting, Learning and Advancing Oncology at OncoDaily Grand Rounds in Madrid
Enrique Grande: Exploring Long-Term Outcomes and Predictive Biomarkers of Pembrolizumab in Advanced Renal Cell Carcinoma
OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.
